Comments on: Advances in the Diagnosis, Classification, Risk Stratification, and Management of Monoclonal Gammopathy of Undetermined Significance: Implications for Recategorizing Disease Entities in the Presence of Evolving Scientific Evidence.

Comments on: Advances in the Diagnosis, Classification, Risk Stratification, and Management of Monoclonal Gammopathy of Undetermined Significance: Implications for Recategorizing Disease Entities in the Presence of Evolving Scientific Evidence. https://newsnetwork.mayoclinic.org/discussion/advances-in-the-diagnosis-classification-risk-stratification-and-management-of-monoclonal-gammopathy-of-undetermined-significance-implications-for-recategorizing-disease-entities-in-the-presence-o/ News Resources Wed, 28 Nov 2018 12:52:50 +0000 hourly 1 https://wordpress.org/?v=7.1.2